Try the modernized beta website. Learn more about the modernization effort.
Working… Menu
Trial record 1 of 1 for:    NCT03624322
Previous Study | Return to List | Next Study

Safety and Tolerability of INP105 (Olanzapine by I231 POD® Device) Nasal Spray in Healthy Volunteers - SNAP 101 (SNAP101)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03624322
Recruitment Status : Completed
First Posted : August 10, 2018
Last Update Posted : October 4, 2018
Information provided by (Responsible Party):
Impel NeuroPharma Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : October 3, 2018
Actual Study Completion Date : October 3, 2018